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Abstract Care from a general practitioner (GP) is one of
the most frequently utilised healthcare services for people
with low back pain and only a small proportion of those
with low back pain who seek care from a GP are referred to
other services. The aim of this systematic review was to
evaluate the evidence on cost-effectiveness of GP care in
non-specific low back pain. We searched clinical and
economic electronic databases, and the reference list of
relevant systematic reviews and included studies to June
2010. Economic evaluations conducted alongside ran-
domised controlled trials with at least one GP care arm
were eligible for inclusion. Two reviewers independently
screened search results and extracted data. Eleven studies
were included; the majority of which conducted a cost-
effectiveness or cost-utility analysis. Most studies investi-
gated the cost-effectiveness of usual GP care. Adding
advice, education and exercise, or exercise and behavioural
counselling, to usual GP care was more cost-effective than
usual GP care alone. Clinical rehabilitation and/or occu-
pational intervention, and acupuncture were more cost-
effective than usual GP care. One study investigated the
cost-effectiveness of guideline-based GP care, and found
that adding exercise and/or spinal manipulation was more
cost-effective than guideline-based GP care alone. In
conclusion, GP care alone did not appear to be the most
cost-effective treatment option for low back pain. GPs can
improve the cost-effectiveness of their treatment by refer-
ring their patients for additional services, such as advice
and exercise, or by providing the services themselves.
Keywords Low back pain  Cost-effectiveness analysis 
Primary health care  Systematic review
Introduction
The direct (healthcare) and indirect (loss of productivity)
costs of low back pain (LBP) have been estimated for
several countries, in a number of studies, with each study
reporting staggering costs [1]. For example, the conserva-
tive estimates for direct and indirect costs of LBP in United
Kingdom were £1,632 and £3,440 million in 1998 [2].
These figures are likely to be higher today. In the United
States, healthcare costs among people with spinal pain
increased by 65% from 1997 to 2005, more rapidly than the
overall healthcare costs, and accounted for 9% of the total
healthcare costs in 2005 [3]. Studies like these illustrate the
need to efficiently use available healthcare budgets when
managing LBP.
An economic evaluation takes into account the costs
relative to the effects (outcomes) in a systematic
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comparison of two or more treatment alternatives [4, 5]. It
does not necessarily answer the question of what the
cheapest intervention is. If an intervention is more effective
than another intervention but associated with higher costs,
the intervention may still be cost-effective if the ratio of
costs and effects is acceptable. Hence, economic evalua-
tions are designed to inform policy makers, clinicians and
consumers about the relative efficiency (value-for-money)
of treatment alternatives.
Care from a general practitioner (GP care) is one of the
most frequently utilised healthcare services for LBP [2, 6].
The role of a GP working in primary care is to triage and
provide first-line care to manage LBP. In managing LBP,
GPs may be the sole provider of care or, in about 20% of
patients [6, 7], GPs refer patients for additional healthcare
services (e.g. physical therapy). The purpose of this sys-
tematic review was to critically appraise and summarise
current evidence, retrieved from economic evaluations
conducted alongside randomised controlled trials, on the
cost-effectiveness of GP care compared to other treatment
options for non-specific LBP.
Methods
We followed the method guidelines of the Cochrane Back
Review Group [8, 9], Campbell and Cochrane Econo-
mic Methods Group (http://www.med.uea.ac.uk/research/
research_econ/cochrane/cochrane_home.htm), and the
NHS Economic Evaluation Database Handbook [10]. Full
economic evaluations (i.e. cost-minimisation, cost-effec-
tiveness, cost-utility or cost-benefit analysis) undertaken
from any perspective conducted alongside randomised
controlled trials were included in this review. Studies
which collected data on costs and/or utilisation but did not
relate this information to a measure of benefit, or did not
make inferences about the relative efficiency of the treat-
ment alternatives, were excluded. Studies that recruited
adults with non-specific LBP of any duration and included
GP care in at least one intervention group were eligible for
this review. We defined GP care as care provided by a
general practitioner or doctor working in primary care.
There was no restriction on the type of comparison group
used. Studies that recruited multiple musculoskeletal con-
ditions (e.g. neck or LBP), or investigated interventions
implemented after spinal surgery were excluded. In addi-
tion, studies had to report costs and effects of the inter-
ventions, or an incremental cost-effectiveness ratio (ICER).
There was no language restriction.
We used the Cochrane Back Review Group’s search
strategies to identify randomised controlled trials in LBP
(http://www.cochrane.iwh.on.ca/pdfs/CBRG_searchstrat_
Sept08.pdf). Economic search terms (e.g. economics, costs
and cost analysis) were developed from search strategies
used by the NHS Economic Evaluation Database (NHS
EED) (http://www.york.ac.uk/inst/crd/nhseedfaq02.htm).
The following databases were searched from inception to 1
June 2010: Medline (via OvidSP), EMBASE (via OvidSP),
CINAHL (via EBSCO), Cochrane Central Register of
Controlled Trials (CENTRAL, via The Cochrane Library),
PsychINFO (via OvidSP), PEDro, the American Economic
Association’s electronic bibliography (EconLit), NHS
EED, and European Network of Health Economic Evalu-
ation Databases (EURONHEED). The reference list of
relevant systematic reviews and included studies were also
searched. See Table 6 of Appendix for an example of a full
search strategy.
Two reviewers independently screened first the titles,
then abstracts (if available), and then full papers. For
each included study, we used the criteria recommended
by the Cochrane Back Review Group [8, 9] to assess the
risk of bias of the trial design, where studies with a score
of 6 or more out of a total of 11 would be considered as
having a low risk of bias [11]. Studies were also rated
using the Consensus on Health Economic Criteria
(CHEC-list) [12] for the quality of the economic evalu-
ation. Studies were included in the analysis regardless of
their risk of bias or quality of economic evaluation. Data
were extracted using a customised data extraction sheet
which was piloted on a cost-effectiveness study [13]
before use. Two reviewers independently performed rat-
ing and data extraction. Publications related to the
included studies (e.g. published protocol or clinical out-
comes paper, listed in Table 7 of Appendix) were used to
assist these processes. Throughout the review, disagree-
ment between the two reviewers were resolved first in
discussion, and then by an independent third reviewer if
necessary.
Data extracted from each study included: (a) the type
and perspective of the economic evaluation, (b) charac-
teristics of participants, (c) treatment comparators, (d) year,
length, country and currency of the study, and (e) identi-
fication, measurement and valuation of costs and outcomes
used in the economic evaluation, and (f) results of the
study. Information on the relative cost-effectiveness of the
interventions was used as the primary outcome in the
review. This is usually reported as an incremental differ-
ence in costs relative to an incremental difference in
effects, e.g. the ICER. Alternatively, where one treatment
incurs lower costs and generates higher benefits compared
to a treatment comparator, an ICER is not necessary and
the treatment is said to be dominant.
For data analysis and presentation, studies were grouped
first according to intervention, then by the type of eco-
nomic evaluation conducted. In addition, regardless of the
interventions investigated, studies reporting ICER using
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generic outcomes [e.g. cost per quality-adjusted life-years
(QALYs) gained] from the same perspective were com-
pared after adjusting for cost differences across countries
and time. We used the cost-effectiveness threshold of the
British National Institute for Health and Clinical Excel-
lence (NICE; GBP20,000 to GBP30,000 per QALY
gained) as an indicator of cost-effectiveness [14, 15]. That
is, if a treatment has an ICER lower than the NICE
threshold when compared to an alternative, the treatment is
said to be relatively cost-effective.
Results
The search yielded 1,961 references and a total of 11
studies were included after screening (Fig. 1). Most full
papers were excluded because they did not include a full
economic evaluation or did not include GP care as at least
one intervention group. All of the included studies were
published in English. The number of participants ranged
from 104 [16] to 1,334 [17]. Most studies included
participants with sub-acute to chronic LBP. Table 1 has the
characteristics of the included studies.
The majority of the studies conducted a cost-effective-
ness and/or cost-utility analysis. There were also two cost-
minimisation [18, 19] and two cost-benefit [20, 21] anal-
yses. One study, which had one- and two-year results
published in two separate papers [22, 23], did not clearly
specify the type of economic evaluation conducted, but the
type of outcomes reported suggested that it was a cost-
effectiveness analysis. Of the 11 included studies, all
studies were conducted in Europe except for one conducted
in the United States [18] and one in Canada [20].
We grouped studies into three groups: GP care alone
versus other treatment (eight studies), GP care plus other
treatment versus other treatment (one study), and GP care
alone versus GP care plus additional treatment (five stud-
ies). Two studies [18, 24] had multiple comparisons and
appeared in more than one treatment contrast. Most studies
evaluated ‘‘usual GP care’’, i.e. they did not specify whe-
ther the treatments followed a protocol or guideline but
provided care that included advice, exercises, rest and
Records identified through 
database searching 
(n = 2945)
Additional records identified 
through other sources 
(n = 3)
Records after duplicates removed
(n = 1961) 
Records screened
(n = 1961) 
Records excluded
(n = 1862) 
Full-text articles assessed 
for eligibility 
(n = 99)
Full-text articles excluded
(n = 88) 
 
• 35 not full economic 
evaluation 
• 23 did not include 
general practice care 
• 13 not randomised 
controlled trials 
• 13 not non-specific 
low back pain 
• 4 repeated 
publications 
Studies included
(n = 11) 
Fig. 1 Flow of studies
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Table 1 Study characteristics
Study ID, type and
perspective
Study details Groups
Hollinghurst et al. [24]
Type: CEA/CUA Participants randomised (n): 435a Usual GP care ± exercise and behavioural
counselling
Perspective: healthcare
sector, patients, societal
Duration of LBP: chronic or recurrent Massage ± exercise and behavioural counselling
Length of follow-up: 12 months Alexander technique (6 lessons) ± exercise and
behavioural counselling
Setting: United Kingdom 2002–2004
Jellema et al. [25]
Type: CEA/CUA Participants randomised (n): 314 Usual GP care
Perspective: societal Duration of LBP: \12 weeks Minimal psychosocial intervention (delivered
by GP)
Length of follow-up: 12 months
Setting: The Netherlands 2001–2003
Johnson et al. [26]
Type: CEA/CUA Participants randomised (n): 234 Usual GP care
Perspective: not stated Duration of LBP: [3 months Exercise and education using a cognitive-
behavioural approach
Length of follow-up: 15 months
Setting: United Kingdom 2002–2003
Karjalainen et al. [22, 23]
Type and perspective:
not stated
Participants randomised (n): 164 Usual GP care
Duration of LBP: [4 weeks but \3 months Usual GP care plus advice, education and exercise
Length of follow-up: 24 months Usual GP care plus advice, education and exercise,
plus worksite visit
Setting: Finland 1998–2000
Kominski et al. [18]
Type: CMA Participants randomised (n): 681 Usual GP care
Perspective: not stated Duration of LBP: mixed Usual GP care plus physiotherapy
Length of follow-up: 18 months Chiropractic care
Setting: United States 1995–1998 Chiropractic care with physical modalities
Kovacs et al. [16]
Type: CEA/CUA Participants randomised (n): 104 Usual GP care
Perspective: not stated Duration of LBP: C14 days Usual GP care plus neuroreflexotherapy
Length of follow-up: 12 months
Setting: Spain, years not specified
Loisel et al. [20]
Type: CEA/CUA and
CBA
Participants randomised (n): 130 Usual GP care
Perspective: insurance
provider
Duration of LBP: [4 weeks absent from work
due to LBP
Clinical rehabilitation (back pain specialist, back
school ± multidisciplinary rehabilitation)
Length of follow-up: mean 6.4 years Occupational intervention (occupation physician
and ergonomics intervention)
Setting: Canada 1991–1993 Clinical rehabilitation plus occupational
intervention
Ratcliffe et al. [27]
Type: CEA/CUA Participants randomised (n): 241 Usual GP care
Perspective: healthcare
sector and societal
Duration of LBP: 4–52 weeks Acupuncture
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prescription of medications with or without referrals to
other services [16, 18, 19, 21]. A number of studies did not
describe details of the GP care, except that it was the
normal or usual care provided by a GP [20, 24–26] which
may include referrals to other services [22, 23, 27]. The
exception was the UK BEAM Trial [17], which provided
training to GPs to deliver guideline care in the management
of LBP (‘‘guideline-based GP care’’).
Risk of bias of the trial design (Table 2)
Two studies did not use concealed allocation [16, 19] and
two were unclear about the randomisation procedure [17,
19]. Assessor blinding was not achieved in most instances
as studies used self-reports to measure outcome and par-
ticipants could not be blinded due to the nature of the
treatment. The only study that satisfied assessor blinding
kept participants unaware that two treatments were being
investigated [25]. Only 4 of the 11 studies were considered
as having a low risk of bias [22–26].
Quality of the economic evaluation (Table 2)
Five studies collected costs appropriate to their chosen
perspective [17, 20, 24, 25, 27]. One study undertook the
economic evaluation from the societal perspective, but
collected only costs associated with the study treatment and
loss of productivity and not the costs of other treatments
Table 2 Risk of bias rated using the criteria of the Cochrane Back
Review Group [8, 9] and methodological quality of the economic
evaluation rated using the Consensus Health Economic Criteria
(CHEC-list) [12]
Risk of bias
score (/11)
CHEC-list
(/19)a
Hollinghurst et al. [24] 7 17 (1)
Jellema et al. [25] 9 18 (1)
Johnson et al. [26] 7 12 (1)
Karjalainen et al. [22, 23] 8 13 (0)
Kominski et al. [18] 5 11 (4)
Kovacs et al. [16] 4 15 (1)
Loisel et al. [20] 5 14 (0)
Ratcliffe et al. [27] 5 19 (0)
Seferlis et al. [19] 4 7 (5)
Skouen et al. [21] 5 14 (1)
UK BEAM Trial Team [17] 5 17 (1)
a The number of items that were not applicable from the CHEC-list is in
parentheses. For example, performing an incremental cost-effectiveness
analysis (Item 13) was not applicable for cost-minimisation or cost-benefit
analysis, and discounting (Item 14) was not applicable for studies with a
follow-up of 1 year or less
Table 1 continued
Study ID, type and
perspective
Study details Groups
Length of follow-up: 24 months
Setting: United Kingdom 1999–2001
Seferlis et al. [19]
Type: CMA Participants randomised (n): 180 Usual GP care
Perspective: not stated Duration of LBP: \2 weeks on sick leave due to LBP Manual therapy
Length of follow-up: 12 months Exercise training
Setting: Sweden, years not specified
Skouen et al. [21]
Type: CBA Participants randomised (n): 211 (195 completed follow up) Usual GP care
Perspective: societal Duration of LBP: sick leave for at least 8 weeks, or sick-listed
for at least 2 months a year for the last 2 years
Light multidisciplinary treatment
Length of follow-up: 24 months after the end of treatment Extensive multidisciplinary treatment
Setting: Norway 1996–1997
UK BEAM Trial Team [17]
Type: CEA/CUA Participants randomised (n): 1,334 (1,287 included in
analysis)
Guideline-based GP care
Perspective: healthcare
sector
Duration of LBP: at least 4 weeks Guideline-based GP care plus exercise
Length of follow-up: 12 months Guideline-based GP care plus spinal manipulation
Setting: United Kingdom 1999–2002 Guideline-based GP care plus combined treatment
(spinal manipulation followed by exercise)
CBA cost-benefit analysis, CEA cost-effectiveness analysis, CMA cost-minimisation analysis, CUA cost-utility analysis
a Data from a fourth group is not included in this review as no comparison was made between this group and GP care
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[21]. Five studies did not state the perspective adopted for
the economic evaluation [16, 18, 19, 22, 23, 26]. Most
studies measured costs using diaries, questionnaires, or
practice or insurance records, and valued costs appropri-
ately using published sources. Where appropriate, most
studies conducted an incremental cost-effectiveness anal-
ysis. The length of follow-up was at least 1 year for all of
the studies. In three of the five studies in which the length
of follow-up was more than 1 year, discounting was
undertaken [21–23, 27]. Just over half the studies con-
ducted a sensitivity analysis to account for uncertainties in
their estimates of costs and effects [16, 17, 20, 24, 25, 27].
GP care alone versus other treatment (Table 3)
Eight studies investigated the cost-effectiveness of usual
GP care alone versus other treatment. The costs of usual
GP care alone were lower than other treatment if only costs
to the healthcare sector were considered [18, 19, 24, 26,
27]. However, usual GP care alone was generally associ-
ated with higher costs than other treatment if a broader
perspective was adopted and the indirect costs associated
with loss of productivity were included [19, 20, 24, 25]. In
studies that conducted a cost-effectiveness or cost-utility
analysis, there were no statistically significant between-
group differences for most comparisons in the clinical
outcomes used in the economic evaluation. The exceptions
were the Alexander technique, which improved pain-free
days (mean between-group difference = 13, 95%
CI = 1–25) [24], and clinical rehabilitation and/or occu-
pational intervention, which reduced days on full sickness
benefits (mean between-group difference range from 190 to
292.7 days) [20]. These treatments also appeared cost-
effective compared to usual GP care alone. Massage was
more costly and less effective than usual GP care alone,
and therefore in this study GP care alone was the dominant
treatment [24]. Ratcliffe et al. [27] found, when costs were
considered from the societal perspective and using inten-
tion-to-treat analysis, that acupuncture was dominant
compared with usual GP care alone.
Two studies conducted a cost-benefit analysis using
sick-listed workers. Loisel et al. [20] showed that clinical
rehabilitation and/or occupational intervention incurred
lower healthcare and income replacement costs compared
to usual GP care alone from the insurance provider’s per-
spective. Skouen et al. [21] found similar results for light
multidisciplinary treatment from the societal perspective,
but interestingly only in male participants.
GP care plus other treatment versus other treatment
Only one study was included in this comparison [24]. This
study found that usual GP care plus exercise and
behavioural counselling was associated with lower costs
than massage or the Alexander technique plus exercise and
behavioural counselling from the perspectives of the
healthcare sector and patient. There were no statistically
significant between-group differences in disability, pain-
free days or QALY outcomes. However, the ICERs for
both treatment alternatives were low, suggesting that these
treatments were cost-effective compared to usual GP care
plus exercise and behavioural counselling (ICER for mas-
sage plus exercise and behavioural counselling = 5,304
per QALY gained, for the Alexander technique plus exer-
cise and behavioural counselling = 5,332 per QALY
gained, in 2005 GBP from the healthcare sector’s
perspective).
GP care alone versus GP care plus additional treatment
Four studies compared usual GP care alone versus usual
GP care plus additional treatment [16, 18, 22–24]. The
costs of usual GP care alone were lower than usual GP care
plus additional treatment if only costs to the healthcare
sector were considered [18, 24]. However, in studies that
included the costs associated with loss of earnings or
productivity, the total costs were lower when additional
treatment was added to usual GP care [16, 22–24]. Three of
the four studies included a cost-effectiveness or cost-utility
analysis (Table 4). Adding exercise and behavioural
counselling to usual GP care improved pain-free days
(mean between-group difference = 11 days, 95% CI 1–23)
and appeared relatively cost-effective from the healthcare
sector’s perspective [24]. Adding advice, education and
exercise with or without worksite visit to usual GP care
improved some outcomes (e.g. pain bothersomeness) and
appeared cost-effective [22, 23]. One study found that
adding neuroreflexology to GP care improved pain and
disability, but not quality of life, outcomes [16]. However,
there was no incremental cost-effectiveness analysis
reported, and an ICER could not be estimated based on the
data provided.
One study investigated the cost-effectiveness of
guideline-based GP care, and found similar results to
studies that investigated usual GP care [17]. From the
healthcare sector’s perspective, guideline-based GP care
alone incurred lower costs compared to guideline-based
GP care plus exercise and/or spinal manipulation. Adding
spinal manipulation to guideline-based GP care was
effective in managing sub-acute to chronic LBP (mean
between-group difference = 0.04 QALYs), and the ICER
was low (£4,800 in 2000 to 2001 GBP per QALY gained
from the healthcare sector’s perspective). In contrast,
adding both spinal manipulation and exercise to guide-
line-based GP care did not statistically significantly
increase the number of QALYs gained compared to
Eur Spine J (2011) 20:1012–1023 1017
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guideline-based GP care alone, but would only cost
£3,800 per QALY gained. This shows that the most
effective treatment may not be the most cost-effective
treatment, as cost-effectiveness analysis considers costs
relative to effects.
Comparing cost-effectiveness across interventions
(Table 5)
Four studies collected costs from the healthcare sector’s
perspective using a common generic outcome (QALYs
Table 3 GP care alone versus other treatment
Study ID and perspective Incremental cost-effectiveness ratio (in cost per one unit of effect gained)
or cost-benefit outcome
Cost-effectiveness/cost-utility analysis
Hollinghurst et al. [24]
Perspective: healthcare sector, patients, societal Compared to GP care alone from healthcare sector’s perspective only, in
2005 GBP
Massage:
•Disability (RMDQ) = 448
•Pain-free day = 26
•QALY gained (EQ-5D) = -34,473 (less effective and more costly)
Alexander technique (6 lessons):
•Disability(RMDQ) = 113
•Pain-free days = 13
•QALY gained (EQ-5D) = 5,899
Jellema et al. [25]
Perspective: societal Minimal psychosocial intervention compared to GP care alone 2002 Euro:
•Disability (RMDQ) = 690
•Recovery rate (% recovered) = 239
•QALY gained (EQ-5D) = 47,348
Johnson et al. [26]
Perspective: not stated, but collected
direct healthcare costs
Exercise and education using a cognitive-behavioural approach compared to
GP care alone = 5,000 in 2003–2004 GBP per QALY gained (EQ-5D)
Loisel et al. [20]
Perspective: insurance provider Compared to GP care alone, in 1998 Canadian dollars per days on full
sickness benefits:
•Clinical rehabilitation = -67.6
•Occupational intervention = -88.4
•Clinical rehabilitation plus occupational intervention = -63.5
Ratcliffe et al. [27]
Perspective: healthcare sector, societal Acupuncture compared to usual GP care, in 2002–2003 GBP per QALY
gained (EQ-5D):
•From healthcare sector’s perspective = 4,241 (95% CI = 191–28,026)
•From societal perspective and with intention-to-treat analysis, acupuncture
dominant
Cost-benefit analysis
Loisel et al. [20]
Perspective: insurance provider Compared to GP care alone, in 1998 Canadian dollars:
•Clinical rehabilitation = 16,176
•Occupational intervention = 16,827
•Clinical rehabilitation plus occupational intervention = 18,585
Skouen et al. [21]
Perspective: societal Light multidisciplinary treatment in male patients compared to usual GP care
alone = 7,240,900 for the male participants (n = 21) over 24 months in
1998 Norwegian kroner
GBP United Kingdom pounds, RMDQ Roland Morris Disability Questionnaire, QALY quality-adjusted life-years
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gained) [17, 24, 26, 27]. Converting all costs to a common
price year showed that all treatments, except for massage,
had an ICER below the NICE threshold and appeared cost-
effective compared to GP care. The two most cost-effective
treatment options were: (a) usual GP care combined with
exercise and behavioural counselling, and (b) guideline-
based GP care combined with spinal manipulation and
exercise.
Discussion
In this systematic review, we identified 11 relevant studies,
most of which examined the cost-effectiveness of GP care
in sub-acute or chronic LBP. When considering costs from
the healthcare sector’s perspective, GP care was associated
with lower costs than other treatment alternatives, and this
finding was consistent across healthcare systems. However,
Table 4 Cost-effective/cost-utility analysis comparing usual GP care alone versus usual GP care plus additional treatment
Study ID and perspective Incremental cost-effectiveness ratio (in cost per one unit of effect gained)
Hollinghurst et al. [24]
Perspective: healthcare sector, patients, societal Usual GP care plus exercise and behavioural counselling compared to
usual GP care alone from the healthcare sector’s perspective only (in
2005 GBP):
•Disability (RMDQ) = 61
•Pain-free days = 9
•QALY gained (EQ-5D) = 2,847
Karjalainen et al. [22, 23]
Perspective: not stated, but collected direct
healthcare and indirect costs
Not conducted, but usual GP care plus advice, education and exercise
with or without work site visit, incurred lower costs and was more
effective compared to usual GP care alone.
Kovacs et al. [16]
Perspective: not stated, but collected direct healthcare
and indirect costs
Not conducted
GBP United Kingdom pounds, RMDQ Roland Morris Disability Questionnaire, QALY quality-adjusted life-years
Table 5 Comparing the incremental cost-effectiveness ratio (ICER) in cost per quality-adjusted life-year gained from the healthcare sector’s
perspective
Treatment Original
currency
ICER in original
currency
ICER in 2005 GBP
(rounded to the nearest pound)
Usual GP care plus exercise and
behavioural counselling [24]
2005 GBP 2,847 2,847
Guideline-based GP care plus spinal
manipulation and exercise [17]
2000–2001 GBP 3,800 4,058
Acupuncture [27] 2002–2003 GBP 4,241 4,415
Guideline-based GP care plus spinal
manipulation [17]
2000–2001 GBP 4,800 5,125
Exercise and education using a cognitive-
behavioural approach [26]
2003–2004 GBP 5,000 5,136
Massage plus exercise and behavioural
counselling [24]
2005 GBP 5,304 5,304
Alexander technique plus exercise and
behavioural counselling [24]
2005 GBP 5,332 5,332
Alexander technique [24] 2005 GBP 5,899 5,899
Guideline-based GP care plus exercise
[17]
2000–2001 GBP 8,300 8,863
Massage [24] 2005 GBP -34,473 -34,473 (more costly and
less effective)
Costs were converted to 2005 GBP using consumer price indices (http://www.statistics.gov.uk/downloads/theme_economy/CPI.pdf)
GBP United Kingdom pounds
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if the costs associated with loss of earnings or changes in
productivity were included, GP care generally incurred
higher costs than other treatments. Most treatments
appeared relatively cost-effective compared to GP care. In
particular, adding advice, education and exercise to usual
GP care or providing clinical rehabilitation and/or occu-
pational intervention or acupuncture were dominant treat-
ment alternatives (i.e. they incurred lower costs and
generated more benefits) compared to usual GP care alone.
Adding exercise and behavioural counselling to usual GP
care, or spinal manipulation to guideline-based GP care,
and using the Alexander technique were more effective and
may also be more cost-effective, as indicated by ICERs
below the NICE threshold of GBP20,000 to GBP30,000.
These findings have important clinical and research
implications. They suggest that GP care alone may not be
the most cost-effective treatment for LBP, yet currently
only around one-fifth of patients with LBP presenting to
GPs are referred to another healthcare service [6, 7]. In
addition, evidence-based management of LBP is typically
based on effectiveness outcomes from trials. Our review
findings suggest that evidence of cost-effectiveness should
also be considered by clinicians and researchers when
making recommendations regarding the management of
LBP. Compared to GP care, when alternative treatments
incur lower costs and are more effective (e.g. acupuncture),
or incur higher costs and are less effective (e.g. massage),
the choice for the most efficient treatment option is straight
forward. In the absence of a clear difference in treatment
effects, the results of economic evaluations can provide
information on the relative efficiency of treatment alter-
natives. Because both the incremental costs and the effects
are taken into account in an economic evaluation, a treat-
ment may be relatively cost-effective compared to an
alternative treatment even if the difference in clinical
effectiveness is small. Hence, future studies should con-
sider including an economic evaluation in order to provide
comprehensive information on both effectiveness and
efficiency of treatments in managing LBP [28]. Conducting
economic evaluations has recently been regarded as a
research priority in musculoskeletal conditions such as
LBP [29].
In all but one study the GP intervention was the usual
care provided by a GP. In contrast, the additional or
alternative services, such as exercise and advice, were
usually delivered according to a defined protocol that
represented best practice. Surveys of usual GP care reveal
low compliance with care recommended in guidelines [6,
7]. Hence, comparing usual GP care to a best practice
alternative potentially under-estimates GP care and needs
to be borne in mind when interpreting the results of this
review. A number of trials found that referring a patient for
additional services was more cost-effective than usual GP
care alone. It is acknowledged that some of the additional
services, e.g. advice/education and exercise prescription,
could be provided by some GPs who manage LBP. Our
pragmatic interpretation of the results of our review is that
GPs aiming to provide cost-effective care should ensure
that their patients receive these additional services, either
by referral (as occurred in the original trial) or by providing
the services themselves.
Most economic evaluations identified by this review
were conducted as cost-effectiveness or cost-utility analy-
ses. While a cost-effective analysis provides data that may
be more meaningful to clinicians (e.g. adding exercise and
behavioural counselling to usual GP care would cost £61 in
2005 GBP per one point gained on the Roland Morris
Disability Questionnaire) [24], a cost-utility analysis pro-
vides information using a generic outcome (most com-
monly cost per QALY gained) that can be compared across
interventions and health conditions [4] and assist policy
makers in making decisions on reimbursing existing or new
treatments. In our review, we used the NICE threshold to
assess the cost-effectiveness of LBP treatments. The NICE
threshold has not changed since 1999. While controversies
exist on the use of such a threshold and on whether the
threshold should be altered [14, 15, 30, 31], most treatments
for LBP have ICERs well below the current threshold. It
needs to be highlighted, however, that the findings of this
review are based on single studies as the heterogeneity of
the included studies prevented the pooling of data. Only 4 of
the 11 included studies had a low risk of bias. In addition,
the findings may be limited to countries with similar
healthcare systems, and, for cost-utility analysis, to popu-
lations where similar utility weights can be expected.
In our review we identified two cost-minimisation
studies [18, 19]. Cost-minimisation analysis is used when
treatment alternatives achieve the same outcomes in
effectiveness, but the appropriateness of its use is contro-
versial because the lack of a demonstrative difference
between two treatments may be due to insufficient power
rather than an absence of effects [32]. Hence, it may be
only appropriate to conduct a cost-minimisation analysis
where an equivalence trial has been conducted [33] or
when the confidence intervals of the between-group treat-
ment effects are narrow enough to rule out potential
treatment effects. For example, Kominski et al. [18] con-
ducted a cost-minimisation analysis based on the results of
a randomised controlled trial, which showed narrow
between-group differences in treatment outcomes [34].
Some authors do not recommend cost-minimisation anal-
ysis as they argue that economic evaluations should be
used to provide estimates of the incremental difference in
costs relative to the incremental difference in effects (i.e.
the incremental cost-effectiveness) rather than hypothesis
testing [32].
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Six similar reviews have been published previously [35–
40]. Results of these reviews were either inconclusive [35–
37, 39], failed to demonstrate economic benefits of inter-
ventions for LBP [38], or focused on the qualitative
description of the economic design [40]. In contrast to
these reviews, and due to an increasing number of available
studies, we were able to selectively include randomised
controlled trials which conducted a full economic evalua-
tion. Compared to a previous review [40], there is a trend
showing that the quality of economic evaluation has
improved, particularly in the identification, measurement
and valuation of cost, and conducting an incremental cost-
effectiveness analysis and sensitivity analysis. It is
important to note that the strength of this review is not that
it gives an ultimate answer to the question which inter-
vention is most cost-effective, but in the summary of all
available economic evaluations for GP care in LBP.
The aim of our review was to investigate the cost-effec-
tiveness of GP care in managing LBP. Therefore, while
studies normally report a range of condition-specific clinical
outcomes, we extracted only the outcomes used in the eco-
nomic evaluation. For the treatments that were dominant
compared to GP care or may be cost-effective when added to
GP care, there is some evidence of small effects in the
clinical outcomes not used in the economic evaluation [22,
23, 41–44]. There is also some evidence of small or short-
term effectiveness on condition-specific outcomes for acu-
puncture [45] and exercise [46] in systematic reviews of
treatment effectiveness, but not so for spinal manipulation
when provided in addition to GP care [47, 48].
Findings of this systematic review suggest that although
GP care alone was often associated with lower treatment
costs from the healthcare sector’s perspective, it may not
provide a cost saving for society if the costs associated with
loss of earnings or productivity are taken into account.
When considering costs relative to effects, GP care alone
may not be cost-effective in managing sub-acute or chronic
LBP. Adding advice, education and exercise to usual GP
care, clinical intervention and/or occupational rehabilita-
tion, and acupuncture appeared to dominate over usual GP
care. Adding exercise and behavioural counselling to usual
GP care, adding exercise and/or spinal manipulation to
guideline-based GP care, and using the Alexander tech-
nique also appeared cost-effective. The cost-effectiveness
of GP care can be improved by referring patients to receive
additional services, such as advice and exercise, or by the
GPs providing the additional services themselves.
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Appendix
See Tables 6 and 7.
Table 6 Search strategy for Medline (via OvidSP)
Part A: Generic search for randomized controlled trials and controlled
clinical trials
1 Clinical Trial .pt.
2 randomized.ab,ti.
3 placebo.ab,ti.
4 dt.fs.
5 randomly.ab,ti.
6 trial.ab,ti.
7 groups.ab,ti.
8 or/1–7
9 Animals/
10 Humans/
11 9 not (9 and 10)
12 8 not 11
Part B: Specific search for low back problems
13 dorsalgia.ti,ab.
14 exp Back Pain/
15 backache.ti,ab.
16 exp Low Back Pain/
17 (lumbar adj pain).ti,ab.
18 lumbago.ti,ab.
19 or/13-18
Part C: Specific search for economic evaluation
20 economics/
21 exp ‘‘costs and cost analysis’’/
22 economics, dental/
23 exp ‘‘economics, hospital’’/
24 economics, medical/
25 economics, nursing/
26 economics, pharmaceutical/
27 (economic$ or cost or costs or costly or costing or price or
prices or pricing or pharmacoeconomic$).ti,ab.
28 (expenditure$ not energy).ti,ab.
29 (value adj1 money).ti,ab.
30 budget$.ti,ab.
31 or/20–30
32 ((energy or oxygen) adj cost).ti,ab.
33 (metabolic adj cost).ti,ab.
34 ((energy or oxygen) adj expenditure).ti,ab.
35 or/32–34
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